Cease compounding tirzepatide after March 19, 2025 , and semaglutide after May 22, 2025
The mechanisms potentially contributing to cardiovascular protection may include effects on weight, glycemic control, blood pressure, and possibly direct effects on vascular inflammation and lipid metabolism, though these mechanisms remain under investigation
Session 3 Side Body & Lateral Line: Re-Stacking Head Over Pelvis Focus: lateral line from ankle to earperoneals, IT band region, lateral pelvis, ribs, and neck
This approach takes advantage of each compounds delivery characteristics
While AOD-9604 mobilizes fat without preserving muscle, ipamorelin's GH elevation provides some muscle-protective effect
PubMed Central GIP receptor co-activation amplifies the insulinotropic effect of GLP-1R signaling the two pathways synergize through distinct intracellular cAMP cascades in -cells and independently modulates adipocyte lipid handling, bone metabolism, and possibly central appetite circuits through neural pathways separate from those engaged by GLP-1R